Efficacy and Safety of Long-acting Injectable Cabotegravir and Rilpivirine in Improving HIV-1 Control in sub-Saharan Africa: Protocol for a Phase 3b Open-Label Randomized Controlled Trial (IMPALA)
长效注射用卡博特韦和利匹韦林在改善撒哈拉以南非洲 HIV-1 控制方面的疗效和安全性:一项 3b 期开放标签随机对照试验方案 (IMPALA)
期刊:Wellcome Open Research
影响因子:
doi:10.12688/wellcomeopenres.23363.1
Tumusiime, Victoria Babirye; Ruzagira, Eugene; Norcross, Claire; Eshun-Wilsonova, Ingrid; Kitonsa, Jonathan; Bahemuka, Ubaldo Mushabe; Grint, Daniel; Kimbugwe, Geofrey; Kakande, Ayoub; Lawrence, David S; Mwendia, Fridah; Van Solingen, Rodica; Van Eygen, Veerle; Addo Boateng, Fafa; Cresswell, Fiona